Site içinde arama yapın

bir ses eklendi Health

2025-10-06 05:14:31

Myelodysplastic Syndrome Drugs Market Analysis: Trends, Growth Drivers, Challenges, and Forecasts (2024–2032)

Myelodysplastic Syndromes (MDS) are a group of rare and serious blood cancers where the bone marrow the factory that makes blood cells doesn't work properly. It produces immature, defective blood cells (a condition called "dysplasia") that die in the marrow or soon after entering the bloodstream, instead of maturing into healthy red blood cells, white blood cells, and platelets....

0 Yorumlar 0 hisse senetleri 212 Views